🇺🇸 FDA
Pipeline program

JADE101

JADE101-02

Phase 2 small_molecule active

Quick answer

JADE101 for IgA Nephropathy is a Phase 2 program (small_molecule) at Jade Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Jade Biosciences
Indication
IgA Nephropathy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials